Population pharmacokinetics of tenofovir alafenamide delivered via an annual subdermal implant in South African women. [PDF]
Beliveau M +9 more
europepmc +1 more source
Treatment selection for adenomyosis based on imaging findings and patient characteristics. [PDF]
Kobayashi H.
europepmc +1 more source
Estimating emergency contraception efficacy with levonorgestrel and copper intrauterine devices. [PDF]
Nourse SE +5 more
europepmc +1 more source
Subdermal implants vs. levonorgestrel intrauterine devices outcomes in reproductive-aged women: a systematic review and meta-analysis. [PDF]
Oliveira JA +4 more
europepmc +1 more source
POLE-mutated atypical endometrial hyperplasia in an adolescent: a 5-year follow-up with LNG-IUS-a case report and literature review. [PDF]
Liu J, Han Y, Wu S.
europepmc +1 more source
Levonorgestrel-releasing intrauterine device treatment in heavy menstrual bleeding: Correlation with endometrial pathology and quality of life. [PDF]
Kolcu SA, Kara E, Yıldız E, Çetin A.
europepmc +1 more source
Conservative hysteroscopic treatment of endometrial intraepithelial neoplasia and endometrial cancer in patients with high surgical risk with mechanical hysteroscopic tissue removal systems: A retrospective cohort study. [PDF]
Arena A +9 more
europepmc +1 more source
Hysteroscopic suture fixation for levonorgestrel-releasing intrauterine system in adenomyosis feasibility and therapeutic outcomes. [PDF]
Chen C, Liu Z, Liang Z, Zhang P, Dong Y.
europepmc +1 more source
Uterine transverse diameter and risk of LNG-IUS malposition in adenomyosis patients: a threshold effect analysis from a retrospective cohort study. [PDF]
Lin Y, Jiang J, Lin H, Yan H, Deng T.
europepmc +1 more source
Suture Fixation of Levonorgestrel-Releasing Device Using the Hysteroscopic Surgery System. [PDF]
Lai Z, Dong J, Zhang Y, Wu J.
europepmc +1 more source

